NPPA issued notice worth Rs 2,328.5 cr for drug overpricing

Image
Press Trust of India New Delhi
Last Updated : Jan 20 2013 | 1:49 AM IST

The government today said demand notices worth up to Rs 2,328.53 crore were issued to pharma firms for drug overpricing between August 27, 1997 and January 31, 2011, out of which only Rs 207.86 crore has been realised.

"On detection of overcharging cases since inception of NPPA on August 27, 1997 and till January 31, 2011, NPPA has issued demand notices in 786 no of cases involving an amount of Rs 2,328.53 crore...," Minister of State for Chemicals and Fertilisers Srikant Kumar Jena said in a written reply in Lok Sabha.

This amount includes overcharging and interest for selling medicines at a price higher than the prices fixed under Drugs Price Control Order (DPCO) 1995, he added.

"Of this Rs 207.86 crore has been realised. Out of this, an amount of Rs 1,930.41 crore is under litigation and pending in various courts and Rs 33.72 crore is pending for recovery with collectors of various states," Jena added.

The National Pharmaceutical Pricing Authority (NPPA) initiates action of overcharging against the companies as per provisions of the DPCO' 1995 and the Essential Commodities Act, 1955.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 25 2011 | 4:33 PM IST

Next Story